Publicaciones en las que colabora con Vicente Vicente Garcia (15)

2023

  1. Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO study

    PLoS ONE, Vol. 18, Núm. 5 May

  2. Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells

    Frontiers in Molecular Biosciences, Vol. 10

2022

  1. Prognostic and Predictive Effects of Tumor and Plasma miR-200c-3p in Locally Advanced and Metastatic Breast Cancer

    Cancers, Vol. 14, Núm. 10

2019

  1. Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy

    Cellular Oncology, Vol. 42, Núm. 5, pp. 627-644

2018

  1. Angiogenic role of miR-20a in breast cancer

    PLoS ONE, Vol. 13, Núm. 4

2017

  1. Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: The EPIPHANY Index

    British Journal of Cancer, Vol. 116, Núm. 8, pp. 994-1001

2016

  1. Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase

    Scientific Reports, Vol. 6

  2. On the necessity of new decision-making methods for cancer-associated, symptomatic, pulmonary embolism

    Thrombosis Research, Vol. 143, pp. 76-85

2015

  1. Delayed recovery and increased severity of paclitaxel-induced peripheral neuropathy in patients with diabetes

    JNCCN Journal of the National Comprehensive Cancer Network, Vol. 13, Núm. 4, pp. 417-423

  2. Effects of conventional neoadjuvant chemotherapy for breast cancer on tumor angiogenesis

    Breast Cancer Research and Treatment, Vol. 151, Núm. 3, pp. 577-587

2014

  1. Role of genetic polymorphisms in NFKB-mediated inflammatory pathways in response to primary chemoradiation therapy for rectal cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 90, Núm. 3, pp. 595-602

  2. Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer

    Breast Cancer Research, Vol. 16, Núm. 1

2013

  1. Association of anthracycline-related cardiac histological lesions with NADPH oxidase functional polymorphisms

    Oncologist, Vol. 18, Núm. 4, pp. 446-453

2012

  1. Clinical and genetic determinants of anthracycline-induced cardiac iron accumulation

    International Journal of Cardiology, Vol. 154, Núm. 3, pp. 282-286

  2. Predictive value of peripheral blood lymphocyte count in breast cancer patients treated with primary chemotherapy

    Breast, Vol. 21, Núm. 4, pp. 468-474